|
|
Volumn 16, Issue 7, 1998, Pages 601-602
|
|
IGF in the clinic [2]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
SOMATOMEDIN;
SOMATOMEDIN BINDING PROTEIN 3;
SOMATOMEDIN C;
SOMATOSTATIN;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
LETTER;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
CLINICAL TRIAL;
DRUG ANTAGONISM;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
NOTE;
UNITED STATES;
CLINICAL TRIALS;
DIABETES MELLITUS, TYPE 1;
DRUG APPROVAL;
HUMANS;
INSULIN-LIKE GROWTH FACTOR I;
RISK ASSESSMENT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0032112011
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0798-601b Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|